Viewing StudyNCT00111540



Ignite Creation Date: 2024-05-05 @ 11:43 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00111540
Status: COMPLETED
Last Update Posted: 2015-02-23
First Post: 2005-05-23

Brief Title: Study to Examine the Effect on Glucose Control and SafetyTolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Diabetes Mellitus Type 2
Keywords:
Name View
exenatide View
diabetes View
Amylin View
exendin-4 View